MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-43-0029750
Signa Pharma Private Limited
Signa Pharma Private Limited - pharma in Kanpur, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.53 Cr
▲ 31.74% YoY
Net profit · FY 2025
₹2.17 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹5.94 Lakh
EBITDA margin 2.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹21 Lakh
Satisfied ₹28.43 Lakh
Company age
42 yrs
Est. 1984
Directors on board
2
As per MCA filings
About Signa Pharma Private Limited
Data last updated:
Signa Pharma Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 March 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24231UP1984PTC006453. Its GSTIN is 09AABCS9045B1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Saurabh Bhargava (Managing Director) and Rekha Bhargava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 123/452 Factory Areafazalganj Kanpur, Uttar Pradesh, India – 208012.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.53 Cr. For the same year it recorded a net profit of ₹2.17 Lakh (net margin 0.9%) and EBITDA of ₹5.94 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹21 Lakh and satisfied charges of ₹28.43 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Signa Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-43-0029750). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24231UP1984PTC006453
Registration Number 006453
Incorporation Date 03 March 1984
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-43-0029750
Recognitions & Rankings of Signa Pharma
Contact details
Signa Pharma Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address123/452 Factory Areafazalganj Kanpur, Uttar Pradesh, India – 208012
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Signa Pharma Private Limited, buy the company report.
Comprehensive company report
Signa Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Signa Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Signa Pharma Private Limited, buy the company report.
Financials of Signa Pharma Private Limited
FY 2025 filings availableSigna Pharma Private Limited reported revenue of ₹2.53 Cr for FY 2025.
Revenue · FY 2025
₹2.53 Cr
Net profit · FY 2025
₹2.17 Lakh margin 0.9%
EBITDA · FY 2025
₹5.94 Lakh margin 2.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▼ 3%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.94 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Signa Pharma Private Limited, buy the company report.
Board of directors of Signa Pharma Private Limited
Signa Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurabh Bhargava | Managing Director | 04 Oct 2011 | 15 Years 0 Months | Current |
| Rekha Bhargava Also directs: Idealife Healthcare Limited | Director | 01 Oct 1985 | 41 Years 0 Months | Current |
Peer comparison
Signa Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medchl Chemicals and Pharmaceuticals Pvt.Ltd. | ₹2.53 Cr (FY 2016) | -37.0% | Secunderabad, Telangana, India | |||
| Srivar Pharma Private Limited | ₹2.53 Cr (FY 2024) | 1250.0% | Hyderabad, Telangana, India | |||
| Signa Pharma Private Limitedthis company | ₹2.53 Cr (FY 2025) | ₹2.17 Lakh | 0.9% | Kanpur, Uttar Pradesh, India | ||
| Pranjivani Wellness Private Limited | ₹2.52 Cr (FY 2024) | -12.0% | Gurgaon, Haryana, India | |||
| Teyro Labs Private Limited | ₹2.51 Cr (FY 2023) | -20.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Signa Pharma Private Limited, buy the company report.
Auditor
Signa Pharma Private Limited is audited by A KAY MEHRA & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A KAY MEHRA & CO | FY 2022 | 050004C |
Shareholding
The shareholding of Signa Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Signa Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹21 Lakh
Satisfied charges
₹28.43 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jul 2019 | 100278296 | Others | ₹10 Lakh | Open | |
| 07 Oct 2016 | 100056434 | Others | ₹11 Lakh | Open | |
| 04 Dec 2009 | 10191069 | Punjab National Bank | ₹3.18 Lakh | Satisfied | |
| 04 Aug 2005 | 80062069 | Pnb | ₹5 Lakh | Satisfied | |
| 07 Jul 2005 | 80062068 | Pnb | ₹2 Lakh | Satisfied |
To see the full charge records of Signa Pharma Private Limited, buy the company report.
Total charge records: 10 View all charges
Legal cases
Signa Pharma Private Limited has 1 court case on record: 1 filed by Signa Pharma. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, UTTARPRADESH | Writ petition | Filed by the company against State of U.P. and 2 Others and 2 others | Pending |
To see the full case history of Signa Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Signa Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Signa Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCS9045B1ZG | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Signa Pharma Private Limited, buy the company report.
Recent activity
Signa Pharma Private Limited has 6 board changes on record since 1985: 2 appointments and 4 cessations. The latest: Rinku Bhargava ceased to be Director on 01 Nov 2024.
AGM
Signa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Signa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Rinku Bhargava ceased to be Director.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100278296 was registered on 06 Jul 2019.
Charges
A charge with Others amounted to Rs. 11.00 Lakh with Charge ID 100056434 was registered on 07 Oct 2016.
Charges
A charge registered on 04 Dec 2009 via Charge ID 10191069 with Punjab National Bank was fully satisfied on 14 Nov 2011.
Charges
A charge registered on 11 Mar 1989 via Charge ID 90271251 with Punjab Nationa Bank was fully satisfied on 14 Nov 2011.
Ceased
Chandra Shekhra Bhargava ceased to be Managing Director.
Ceased
Saurabh Bhargava ceased to be Director.
Appointed
Saurabh Bhargava was appointed as Managing Director.
Ceased
Rama Bhargava ceased to be Director.
Charges
A charge registered on 04 Aug 2005 via Charge ID 80062069 with Pnb was fully satisfied on 18 Jan 2011.
16 earlier events are in the company report.
Frequently asked questions
Signa Pharma is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 March 1984 (42+ years old) and is registered under CIN U24231UP1984PTC006453.
Signa Pharma has 2 current directors:
- Saurabh Bhargava - Managing Director
- Rekha Bhargava - Director
The latest financial statements of Signa Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Signa Pharma is 09AABCS9045B1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Signa Pharma is U24231UP1984PTC006453. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Signa Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Signa Pharma was incorporated on 03 March 1984, making it 42+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Signa Pharma by revenue are Medchl Chemicals and Pharmaceuticals Pvt.Ltd, Srivar Pharma Private Limited, Pranjivani Wellness Private Limited, Teyro Labs Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rinku Bhargava ceased to be Director on 01 Nov 2024. Chandra Shekhra Bhargava ceased to be Managing Director on 31 Oct 2011. Saurabh Bhargava ceased to be Director on 31 Oct 2011. Signa Pharma has 6 board changes on record in total.
Yes, Signa Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-43-0029750).
The registered office of Signa Pharma is at 123452 Factory Areafazalganj Kanpur, Uttar Pradesh, India – 208012.